aluates Reports

$ 0.0

Automative

Global Celecoxib Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: June 2025

Report Code: QYRE-Auto-26G8960

BUY CHAPTERS

Global Celecoxib Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-26G8960

Report

June 2025

Pages:133

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

TEVA

Mylan NV

Apotex

Lupin Ltd

Hengrui Medicine

Celecoxib Market Size

In 2024, the global market size of Celecoxib was estimated to be worth US$ 1492 million and is forecast to reach approximately US$ 2604 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.

Celecoxib Market

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.

The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.

Data show that more than 400 million people worldwide are currently affected by joint diseases.

The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.

The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.

At present, the burden of chronic diseases will increase by 40% due to the aging of the population.

As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.

Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.

At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.

At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.

It accounted for 63.39% of the global market in 2019.

As of 2019, China relies entirely on Pfizer for celecoxib imports.

Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Celecoxib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celecoxib.

The Celecoxib market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Celecoxib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Celecoxib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Celecoxib Market Report

Report Metric	Details
Report Name	Celecoxib Market
CAGR	8.4%
Segment by Type	50mg 100mg 200mg 400mg
Segment by Application	Rheumatoid arthritis osteoarthritis Acute pain Musculoskeletal pain Other diseases
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer Inc, Teva, Mylan, Apotex, Lupin, Hengrui Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Celecoxib in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Celecoxib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Celecoxib sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Celecoxib Market share by region?

Ans: The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.

Who are the main players in the Celecoxib Market report?

Ans: The main players in the Celecoxib Market are Pfizer Inc, Teva, Mylan, Apotex, Lupin, Hengrui Medicine

What are the Application segmentation covered in the Celecoxib Market report?

Ans: The Applications covered in the Celecoxib Market report are Rheumatoid arthritis, osteoarthritis, Acute pain, Musculoskeletal pain, Other diseases

What are the Type segmentation covered in the Celecoxib Market report?

Ans: The Types covered in the Celecoxib Market report are 50mg, 100mg, 200mg, 400mg

1 Study Coverage

1.1 Celecoxib Product Introduction

1.2 Market by Type

1.2.1 Global Celecoxib Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 50mg

1.2.3 100mg

1.2.4 200mg

1.2.5 400mg

1.3 Market by Application

1.3.1 Global Celecoxib Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Rheumatoid arthritis

1.3.3 osteoarthritis

1.3.4 Acute pain

1.3.5 Musculoskeletal pain

1.3.6 Other diseases

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Celecoxib Market Size Estimates and Forecasts

2.1.1 Global Celecoxib Revenue 2020-2031

2.1.2 Global Celecoxib Sales 2020-2031

2.2 Celecoxib Market Size by Region: 2024 Versus 2031

2.3 Celecoxib Sales by Region (2020-2031)

2.3.1 Global Celecoxib Sales by Region: 2020-2025

2.3.2 Global Celecoxib Sales Forecast by Region (2026-2031)

2.3.3 Global Celecoxib Sales Market Share by Region (2020-2031)

2.4 Celecoxib Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Celecoxib Revenue by Region: 2020-2025

2.4.2 Global Celecoxib Revenue Forecast by Region (2026-2031)

2.4.3 Global Celecoxib Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Celecoxib Sales by Type (2020-2031)

3.1.1.1 Global Celecoxib Sales Volume by Type (2020-2031)

3.1.1.2 Global Celecoxib Sales Market Share by Type (2020-2031)

3.1.2 Global Celecoxib Revenue by Type (2020-2031)

3.1.2.1 Global Celecoxib Revenue by Type (2020-2031)

3.1.2.2 Global Celecoxib Revenue Market Share by Type (2020-2031)

3.1.3 Celecoxib Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Celecoxib Sales by Application (2020-2031)

3.2.1.1 Global Celecoxib Sales Volume by Application (2020-2031)

3.2.1.2 Global Celecoxib Sales Market Share by Application (2020-2031)

3.2.2 Global Celecoxib Revenue by Application (2020-2031)

3.2.2.1 Global Celecoxib Revenue by Application (2020-2031)

3.2.2.2 Global Celecoxib Revenue Market Share by Application (2020-2031)

3.2.3 Celecoxib Average Selling Price (ASP) by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 50mg of Celecoxib Revenue Market Share by Application

3.3.2 100mg of Celecoxib Revenue Market Share by Application

3.3.3 200mg of Celecoxib Revenue Market Share by Application

3.3.4 400mg of Celecoxib Revenue Market Share by Application

4 Global Celecoxib by Manufacturers

4.1 Global Top Celecoxib Manufacturers by Sales (2020-2025)

4.1.1 Global Celecoxib Sales by Manufacturer (2020-2025)

4.1.2 Global Celecoxib Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Celecoxib Manufacturers by Revenue (2020-2025)

4.2.1 Global Celecoxib Revenue by Manufacturer (2020-2025)

4.2.2 Global Celecoxib Revenue Share by Manufacturer (2020-2025)

4.3 Global Celecoxib Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Celecoxib Manufacturers Covered: Ranking by Revenue

4.4.2 Global Celecoxib Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Celecoxib Manufacturing Base Distribution, Product Type

4.5.1 Celecoxib Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Celecoxib Market

4.5.3 Manufacturers Celecoxib Product Type and Application

4.5.4 50mg Market Sales of Celecoxib by Manufacturer

4.5.5 100mg Market Sales of Celecoxib by Manufacturer

4.5.6 200mg Market Sales of Celecoxib by Manufacturer

4.5.7 400mg Market Sales of Celecoxib by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Pfizer Inc

5.1.1 Pfizer Inc Company Information

5.1.2 Pfizer Inc Description, Business Overview

5.1.3 Pfizer Inc Celecoxib Products Offered

5.1.4 Pfizer Inc Celecoxib Sales, Revenue and Gross Margin (2020-2025)

5.1.5 Pfizer Inc Celecoxib Sales by Product in 2024

5.1.6 Pfizer Inc Celecoxib Sales by Application in 2024

5.1.7 Pfizer Inc Celecoxib Sales by Geographic Area in 2024

5.1.8 Pfizer Inc Recent Developments

5.2 Teva

5.2.1 Teva Company Information

5.2.2 Teva Description, Business Overview

5.2.3 Teva Celecoxib Products Offered

5.2.4 Teva Celecoxib Sales, Revenue and Gross Margin (2020-2025)

5.2.5 Teva Celecoxib Sales by Product in 2024

5.2.6 Teva Celecoxib Sales by Application in 2024

5.2.7 Teva Celecoxib Sales by Geographic Area in 2024

5.2.8 Teva Recent Developments

5.3 Mylan

5.3.1 Mylan Company Information

5.3.2 Mylan Description, Business Overview

5.3.3 Mylan Celecoxib Products Offered

5.3.4 Mylan Celecoxib Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Mylan Celecoxib Sales by Product in 2024

5.3.6 Mylan Celecoxib Sales by Application in 2024

5.3.7 Mylan Celecoxib Sales by Geographic Area in 2024

5.3.8 Mylan Recent Developments

5.4 Apotex

5.4.1 Apotex Company Information

5.4.2 Apotex Description, Business Overview

5.4.3 Apotex Celecoxib Products Offered

5.4.4 Apotex Celecoxib Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Apotex Celecoxib Sales by Product in 2024

5.4.6 Apotex Celecoxib Sales by Application in 2024

5.4.7 Apotex Celecoxib Sales by Geographic Area in 2024

5.4.8 Apotex Recent Developments

5.5 Lupin

5.5.1 Lupin Company Information

5.5.2 Lupin Description, Business Overview

5.5.3 Lupin Celecoxib Products Offered

5.5.4 Lupin Celecoxib Sales, Revenue and Gross Margin (2020-2025)

5.5.5 Lupin Celecoxib Sales by Product in 2024

5.5.6 Lupin Celecoxib Sales by Application in 2024

5.5.7 Lupin Celecoxib Sales by Geographic Area in 2024

5.5.8 Lupin Recent Developments

5.6 Hengrui Medicine

5.6.1 Hengrui Medicine Company Information

5.6.2 Hengrui Medicine Description, Business Overview

5.6.3 Hengrui Medicine Celecoxib Products Offered

5.6.4 Hengrui Medicine Celecoxib Sales, Revenue and Gross Margin (2020-2025)

5.6.5 Hengrui Medicine Celecoxib Sales by Product in 2024

5.6.6 Hengrui Medicine Celecoxib Sales by Application in 2024

5.6.7 Hengrui Medicine Celecoxib Sales by Geographic Area in 2024

5.6.8 Hengrui Medicine Recent Developments

6 North America

6.1 North America Celecoxib Market Size YoY Growth 2020-2031

6.2 North America Celecoxib Market Facts & Figures by Country

6.2.1 North America Celecoxib Sales by Country (2020-2031)

6.2.2 North America Celecoxib Revenue by Country (2020-2031)

6.3 North America Celecoxib Sales by Type (2020-2025)

6.4 North America Celecoxib Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Celecoxib Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Celecoxib Market Facts & Figures by Region

7.2.1 Asia-Pacific Celecoxib Sales by Region (2020-2031)

7.2.2 Asia-Pacific Celecoxib Revenue by Region (2020-2031)

7.3 Asia-Pacific Celecoxib Sales by Type (2020-2025)

7.4 Asia-Pacific Celecoxib Sales by Application (2020-2025)

8 Europe

8.1 Europe Celecoxib Market Size YoY Growth 2020-2031

8.2 Europe Celecoxib Market Facts & Figures by Country

8.2.1 Europe Celecoxib Sales by Country (2020-2031)

8.2.2 Europe Celecoxib Revenue by Country (2020-2031)

8.3 Europe Celecoxib Sales by Type (2020-2025)

8.4 Europe Celecoxib Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Celecoxib Market Size YoY Growth 2020-2031

9.2 Latin America Celecoxib Market Facts & Figures by Country

9.2.1 Latin America Celecoxib Sales by Country (2020-2031)

9.2.2 Latin America Celecoxib Revenue by Country (2020-2031)

9.3 Latin America Celecoxib Sales by Type (2020-2025)

9.4 Latin America Celecoxib Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Celecoxib Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Celecoxib Market Facts & Figures by Country

10.2.1 Middle East and Africa Celecoxib Sales by Country (2020-2031)

10.2.2 Middle East and Africa Celecoxib Revenue by Country (2020-2031)

10.3 Middle East and Africa Celecoxib Sales by Type (2020-2025)

10.4 Middle East and Africa Celecoxib Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Celecoxib Supply Chain Analysis

11.2 Celecoxib Key Raw Materials and Upstream Suppliers

11.3 Celecoxib Clients Analysis

11.4 Celecoxib Sales Channel and Sales Model Analysis

11.4.1 Celecoxib Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Celecoxib Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Celecoxib Distributors

12 Celecoxib Market Dynamics

12.1 Celecoxib Industry Trends

12.2 Celecoxib Market Drivers

12.3 Celecoxib Market Challenges

12.4 Celecoxib Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

TEVA

Mylan NV

Apotex

Lupin Ltd

Hengrui Medicine

List of Tables

Table 1. Global Celecoxib Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Celecoxib Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Celecoxib Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Celecoxib Sales by Region (2020-2025) & (K Units)

Table 5. Global Celecoxib Sales Forecast by Region (2026-2031) & (K Units)

Table 6. Global Celecoxib Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Celecoxib Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Celecoxib Sales Volume by Type (2020-2025) & (K Units)

Table 9. Global Celecoxib Sales Volume by Type (2026-2031) & (K Units)

Table 10. Global Celecoxib Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Celecoxib Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Celecoxib Sales Volume by Application (2020-2025) & (K Units)

Table 13. Global Celecoxib Sales Volume by Application (2026-2031) & (K Units)

Table 14. Global Celecoxib Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Celecoxib Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Celecoxib Sales by Manufacturer (2020-2025) & (K Units)

Table 17. Global Celecoxib Sales Share by Manufacturer (2020-2025)

Table 18. Celecoxib Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Celecoxib Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Celecoxib Price (2020-2025) & (US$/Unit)

Table 21. Ranking of Global Top Celecoxib Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Celecoxib Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Celecoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2024)

Table 24. Celecoxib Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Celecoxib Market

Table 26. Manufacturers Celecoxib Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Pfizer Inc Company Information

Table 29. Pfizer Inc Description and Business Overview

Table 30. Pfizer Inc Celecoxib Product

Table 31. Pfizer Inc Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 32. Pfizer Inc Sales Proportion of Celecoxib by Product in 2024

Table 33. Pfizer Inc Sales Proportion of Celecoxib by Application in 2024

Table 34. Pfizer Inc Sales Proportion of Celecoxib by Geographic Area in 2024

Table 35. Pfizer Inc Recent Developments

Table 36. Teva Company Information

Table 37. Teva Description and Business Overview

Table 38. Teva Celecoxib Product

Table 39. Teva Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 40. Teva Sales Proportion of Celecoxib by Product in 2024

Table 41. Teva Sales Proportion of Celecoxib by Application in 2024

Table 42. Teva Sales Proportion of Celecoxib by Geographic Area in 2024

Table 43. Teva Recent Developments

Table 44. Mylan Company Information

Table 45. Mylan Description and Business Overview

Table 46. Mylan Celecoxib Product

Table 47. Mylan Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 48. Mylan Sales Proportion of Celecoxib by Product in 2024

Table 49. Mylan Sales Proportion of Celecoxib by Application in 2024

Table 50. Mylan Sales Proportion of Celecoxib by Geographic Area in 2024

Table 51. Mylan Recent Developments

Table 52. Apotex Company Information

Table 53. Apotex Description and Business Overview

Table 54. Apotex Celecoxib Product

Table 55. Apotex Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 56. Apotex Sales Proportion of Celecoxib by Product in 2024

Table 57. Apotex Sales Proportion of Celecoxib by Application in 2024

Table 58. Apotex Sales Proportion of Celecoxib by Geographic Area in 2024

Table 59. Apotex Recent Developments

Table 60. Lupin Company Information

Table 61. Lupin Description and Business Overview

Table 62. Lupin Celecoxib Product

Table 63. Lupin Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 64. Lupin Sales Proportion of Celecoxib by Product in 2024

Table 65. Lupin Sales Proportion of Celecoxib by Application in 2024

Table 66. Lupin Sales Proportion of Celecoxib by Geographic Area in 2024

Table 67. Lupin Recent Developments

Table 68. Hengrui Medicine Company Information

Table 69. Hengrui Medicine Description and Business Overview

Table 70. Hengrui Medicine Celecoxib Product

Table 71. Hengrui Medicine Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Hengrui Medicine Sales Proportion of Celecoxib by Product in 2024

Table 73. Hengrui Medicine Sales Proportion of Celecoxib by Application in 2024

Table 74. Hengrui Medicine Sales Proportion of Celecoxib by Geographic Area in 2024

Table 75. Hengrui Medicine Recent Developments

Table 76. North America Celecoxib Sales by Country (2020-2025) & (K Units)

Table 77. North America Celecoxib Sales by Country (2026-2031) & (K Units)

Table 78. North America Celecoxib Revenue by Country (2020-2025) & (US$ Million)

Table 79. North America Celecoxib Revenue by Country (2026-2031) & (US$ Million)

Table 80. North America Celecoxib Sales by Type (2020-2025) & (K Units)

Table 81. North America Celecoxib Sales by Application (2020-2025) & (K Units)

Table 82. Asia-Pacific Celecoxib Sales by Region (2020-2025) & (K Units)

Table 83. Asia-Pacific Celecoxib Sales by Region (2026-2031) & (K Units)

Table 84. Asia-Pacific Celecoxib Revenue by Region (2020-2025) & (US$ Million)

Table 85. Asia-Pacific Celecoxib Revenue by Region (2026-2031) & (US$ Million)

Table 86. Asia-Pacific Celecoxib Sales by Type (2020-2025) & (K Units)

Table 87. Asia-Pacific Celecoxib Sales by Application (2020-2025) & (K Units)

Table 88. Europe Celecoxib Sales by Country (2020-2025) & (K Units)

Table 89. Europe Celecoxib Sales by Country (2026-2031) & (K Units)

Table 90. Europe Celecoxib Revenue by Country (2020-2025) & (US$ Million)

Table 91. Europe Celecoxib Revenue by Country (2026-2031) & (US$ Million)

Table 92. Europe Celecoxib Sales by Type (2020-2025) & (K Units)

Table 93. Europe Celecoxib Sales by Application (2020-2025) & (K Units)

Table 94. Latin America Celecoxib Sales by Country (2020-2025) & (K Units)

Table 95. Latin America Celecoxib Sales by Country (2026-2031) & (K Units)

Table 96. Latin America Celecoxib Revenue by Country (2020-2025) & (US$ Million)

Table 97. Latin America Celecoxib Revenue by Country (2026-2031) & (US$ Million)

Table 98. Latin America Celecoxib Sales by Type (2020-2025) & (K Units)

Table 99. Latin America Celecoxib Sales by Application (2020-2025) & (K Units)

Table 100. Middle East and Africa Celecoxib Sales by Country (2020-2025) & (K Units)

Table 101. Middle East and Africa Celecoxib Sales by Country (2026-2031) & (K Units)

Table 102. Middle East and Africa Celecoxib Revenue by Country (2020-2025) & (US$ Million)

Table 103. Middle East and Africa Celecoxib Revenue by Country (2026-2031) & (US$ Million)

Table 104. Middle East and Africa Celecoxib Sales by Type (2020-2025) & (K Units)

Table 105. Middle East and Africa Celecoxib Sales by Application (2020-2025) & (K Units)

Table 106. Celecoxib Key Raw Materials, Industry Status and Trend

Table 107. Celecoxib Key Raw Materials and Upstream Suppliers

Table 108. Celecoxib Clients Status and Trend

Table 109. Celecoxib Typical Clients

Table 110. Celecoxib Distributors

Table 111. Celecoxib Market Trends

Table 112. Celecoxib Market Drivers

Table 113. Celecoxib Market Challenges

Table 114. Celecoxib Market Restraints

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

Table 118. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Celecoxib Product Picture

Figure 2. Global Celecoxib Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Celecoxib Sales Market Share by Type in 2024 & 2031

Figure 4. 50mg Product Picture

Figure 5. 100mg Product Picture

Figure 6. 200mg Product Picture

Figure 7. 400mg Product Picture

Figure 8. Global Celecoxib Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 9. Global Celecoxib Sales Market Share by Application in 2024 & 2031

Figure 10. Rheumatoid arthritis

Figure 11. osteoarthritis

Figure 12. Acute pain

Figure 13. Musculoskeletal pain

Figure 14. Other diseases

Figure 15. Celecoxib Report Years Considered

Figure 16. Global Celecoxib Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Celecoxib Market Size 2020-2031 (US$ Million)

Figure 18. Global Celecoxib Sales 2020-2031 (K Units)

Figure 19. Global Celecoxib Sales Market Share Forecast by Region (2020-2031)

Figure 20. Global Celecoxib Revenue Market Share by Region (2020-2031)

Figure 21. Global Celecoxib Sales Market Share Forecast by Type (2020-2031)

Figure 22. Global Celecoxib Revenue Market Share Forecast by Type (2020-2031)

Figure 23. Celecoxib Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)

Figure 24. Global Celecoxib Sales Market Share Forecast by Application (2020-2031)

Figure 25. Global Celecoxib Revenue Market Share Forecast by Application (2020-2031)

Figure 26. Celecoxib Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)

Figure 27. 50mg of Celecoxib Revenue Market Share by Application, 2024 VS 2031

Figure 28. 100mg of Celecoxib Revenue Market Share by Application, 2024 VS 2031

Figure 29. 200mg of Celecoxib Revenue Market Share by Application, 2024 VS 2031

Figure 30. 400mg of Celecoxib Revenue Market Share by Application, 2024 VS 2031

Figure 31. Global Celecoxib Sales Share by Manufacturer in 2024

Figure 32. Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 33. 50mg Market Sales Proportion by Manufacturer in 2024

Figure 34. 100mg Market Sales Proportion by Manufacturer in 2024

Figure 35. 200mg Market Sales Proportion by Manufacturer in 2024

Figure 36. 400mg Market Sales Proportion by Manufacturer in 2024

Figure 37. North America Celecoxib Revenue 2020-2031 (US$ Million)

Figure 38. North America Celecoxib Sales Market Share by Type (2020-2025)

Figure 39. North America Celecoxib Sales Market Share by Application (2020-2025)

Figure 40. Asia-Pacific Celecoxib Revenue 2020-2031 (US$ Million)

Figure 41. Asia-Pacific Celecoxib Sales Market Share by Region (2020-2031)

Figure 42. Asia-Pacific Celecoxib Revenue Market Share by Region (2020-2031)

Figure 43. Asia-Pacific Celecoxib Sales Market Share by Type (2020-2025)

Figure 44. Asia-Pacific Celecoxib Sales Market Share by Application (2020-2025)

Figure 45. Europe Celecoxib Revenue Growth Rate 2020-2031 (US$ Million)

Figure 46. Europe Celecoxib Sales Market Share by Country (2020-2031)

Figure 47. Europe Celecoxib Revenue Market Share by Country (2020-2031)

Figure 48. Europe Celecoxib Sales Market Share by Type (2020-2025)

Figure 49. Europe Celecoxib Sales Market Share by Application (2020-2025)

Figure 50. Latin America Celecoxib Revenue Growth Rate 2020-2031 (US$ Million)

Figure 51. Latin America Celecoxib Sales Market Share by Country (2020-2031)

Figure 52. Latin America Celecoxib Revenue Market Share by Country (2020-2025)

Figure 53. Latin America Celecoxib Sales Market Share by Type (2020-2025)

Figure 54. Latin America Celecoxib Sales Market Share by Application (2020-2025)

Figure 55. Middle East and Africa Celecoxib Revenue Growth Rate 2020-2031 (US$ Million)

Figure 56. Middle East and Africa Celecoxib Sales Market Share by Country (2020-2031)

Figure 57. Middle East and Africa Celecoxib Revenue Market Share by Country (2020-2031)

Figure 58. Middle East and Africa Celecoxib Sales Market Share by Type (2020-2025)

Figure 59. Middle East and Africa Celecoxib Sales Market Share by Application (2020-2025)

Figure 60. Celecoxib Supply Chain (Upstream and Downstream Market)

Figure 61. Global Production Market Share of Celecoxib Raw Materials by Region in 2024

Figure 62. Celecoxib Distribution Channels

Figure 63. Global Celecoxib Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 64. Global Celecoxib Percentage 2020-2031: Online Sales VS Offline Sales

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Rofecoxib Market Insights Forecast to 2030

Global Celecoxib API Market Research Report 2025

Global Piroxicam Market Research Report 2024

Global Anti inflammatory Agents Market Research Report 2024

Cox 2 Inhibitors Market

Global Cyclooxygenase 2 Inhibitor Market Research Report 2024

Global Meloxicam Drugs Market Research Report 2024

Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030

Global Nonsteroidal Anti Inflammatory Drugs NSAIDs Market Research Report 2024

Global Cyclooxygenase 2 Inhibitor COVID 19 Market Research Report 2024

Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025

Global Ketoprofen Market Insights Forecast to 2030

Global Tenoxicam Market Research Report 2024

Global Nimesulide Market Research Report 2024

Global Fenoprofen Calcium Market Research Report 2024

Global Piroxicam Patch Market Research Report 2024

Global Ketorolac Market Research Report 2024

Global Lornoxicam Tablets Market Research Report 2024

Global Pets NSAIDs Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions